APA (7th ed.) Citation

Halacova, N., Brndiarova, M., Slenker, B., Ruzinak Bobcakova, A., Schniederova, M., Markocsy, A., . . . Jesenak, M. (2026). Complement Inhibitors and the Risk of (Breakthrough) Infections—Critical Analysis and Preventive Strategies. Biologics, 6(1), 3. https://doi.org/10.3390/biologics6010003

Chicago Style (17th ed.) Citation

Halacova, Nikola, Miroslava Brndiarova, Branislav Slenker, Anna Ruzinak Bobcakova, Martina Schniederova, Adam Markocsy, Ingrid Urbancikova, and Milos Jesenak. "Complement Inhibitors and the Risk of (Breakthrough) Infections—Critical Analysis and Preventive Strategies." Biologics 6, no. 1 (2026): 3. https://doi.org/10.3390/biologics6010003.

MLA (9th ed.) Citation

Halacova, Nikola, et al. "Complement Inhibitors and the Risk of (Breakthrough) Infections—Critical Analysis and Preventive Strategies." Biologics, vol. 6, no. 1, 2026, p. 3, https://doi.org/10.3390/biologics6010003.